Search Results 331-340 of 18201 for creatine evidence

1. Testing Whether The Addition Of Carboplatin Chemotherapy To Cabazitaxel Chemotherapy Will Improve Outcomes Compared To Cabazitaxel Alone In People With Castrate-Resistant Prostate Cancer That Has Spread Beyond The Prostate To Other Parts Of The Body - Mayo Clinic

   ... evidence of bone marrow infiltration by tumor in which case \> 75 x 10\^3/uL are allowed) (within 28 days prior to step 2 randomization) * STEP 2 ...

2. Study of bb2121 in Multiple Myeloma - Clinical Trials

   Evidence of cell membrane BCMA expression, as ... Inadequate renal function defined by creatinine clearance ≤5 ml/min using the Cockcroft-Gault formula.

3. A Study of Tazemetostat in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Endometrial Cancer - Mayo Clinic

   Patients with central nervous system (CNS) disease should demonstrate evidence of stabilization after the 28-day time point after definitive treatment. Full ...

4. A Study To Assess Omega-3 Replacement With Krill Oil In Disease Management Of System Lupus Erythematosus (SLE) - Mayo Clinic

   ... creatinine ratio, or serum creatinine > 2.5mg/dL). Have clinical evidence of significant unstable or uncontrolled acute or chronic diseases not related to ...

5. Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis - Mayo Clinic

   Serum creatinine ≥ 2.0 mg/dL or estimated creatinine clearance < 60 mL/min (using the Cockcroft-Gault equation); ... evidence of active infection;; Have human ...

6. Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer - Mayo Clinic

   Serum creatinine < 1.5 x ULN. Exclusion Criteria: Any of the following ... Evidence of active or acute (i.e. current, or recent within 4 weeks prior to ...

7. S0820, Adenoma and Second Primary Prevention Trial - Mayo Clinic

   One-year post-operative colonoscopy and CT scans of chest, abdomen & pelvis showing no evidence of disease ... Serum creatinine ≤ 1.5 x IULN; Zubrod PS 0-1 ...

8. Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Metastatic Colorectal Cancer (OBERTO) - Mayo Clinic

   Serum creatinine ≤1.5 × ULN set by the site and creatinine clearance >30 mL/min using Cockroft formula. ... evidence of acute ischemia or active conduction ...

9. Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer - Mayo Clinic

   Patient must have no evidence of metastatic disease on physical exam ... Serum creatinine within normal institutional limits or creatinine clearance ≥ 50 ml/min ...

10. Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma - Mayo Clinic

    Estimated serum creatinine clearance (CrCl) of ≥ 50 mL/min using the ... evidence of liver damage) infection. Subject has history of other malignancy ...